A phase III randomized trial of chemoimmunotherapy comprising gemcitabine and capecitabine with or without telomerase vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer.
Gary William Middleton
No relevant relationships to disclose
Juan W. Valle
No relevant relationships to disclose
Jonathan Wadsley
No relevant relationships to disclose
David Propper
No relevant relationships to disclose
Fareeda Y. Coxon
No relevant relationships to disclose
Paul J. Ross
No relevant relationships to disclose
Srinivasan Madhusudan
No relevant relationships to disclose
Tom Roques
No relevant relationships to disclose
David Cunningham
No relevant relationships to disclose
Philippa Corrie
No relevant relationships to disclose
William Greenhalf
No relevant relationships to disclose
Victoria Shaw
No relevant relationships to disclose
Trevor F. Cox
No relevant relationships to disclose
Paul Silcocks
No relevant relationships to disclose
Gemma Nanson
No relevant relationships to disclose
John P. Neoptolemos
No relevant relationships to disclose